These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18581391)

  • 1. New L-dopa codrugs as potential antiparkinson agents.
    Sozio P; Iannitelli A; Cerasa LS; Cacciatore I; Cornacchia C; Giorgioni G; Ricciutelli M; Nasuti C; Cantalamessa F; Di Stefano A
    Arch Pharm (Weinheim); 2008 Jul; 341(7):412-7. PubMed ID: 18581391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and study of L-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties.
    Pinnen F; Cacciatore I; Cornacchia C; Sozio P; Iannitelli A; Costa M; Pecci L; Nasuti C; Cantalamessa F; Di Stefano A
    J Med Chem; 2007 May; 50(10):2506-15. PubMed ID: 17451233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.
    Di Stefano A; Sozio P; Cocco A; Iannitelli A; Santucci E; Costa M; Pecci L; Nasuti C; Cantalamessa F; Pinnen F
    J Med Chem; 2006 Feb; 49(4):1486-93. PubMed ID: 16480285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codrugs linking L-dopa and sulfur-containing antioxidants: new pharmacological tools against Parkinson's disease.
    Pinnen F; Cacciatore I; Cornacchia C; Sozio P; Cerasa LS; Iannitelli A; Nasuti C; Cantalamessa F; Sekar D; Gabbianelli R; Falcioni ML; Di Stefano A
    J Med Chem; 2009 Jan; 52(2):559-63. PubMed ID: 19093882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of rat striatal L-dopa and DA concentration after intraperitoneal administration of L-dopa prodrugs in liposomal formulations.
    Di Stefano A; Carafa M; Sozio P; Pinnen F; Braghiroli D; Orlando G; Cannazza G; Ricciutelli M; Marianecci C; Santucci E
    J Control Release; 2004 Sep; 99(2):293-300. PubMed ID: 15380638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
    Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
    Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
    Hornykiewicz O
    Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease.
    Rocchitta G; Migheli R; Esposito G; Marchetti B; Desole MS; Miele E; Serra PA
    J Pineal Res; 2006 Apr; 40(3):204-13. PubMed ID: 16499555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic intermittent L-DOPA treatment induces changes in dopamine release.
    Lundblad M; af Bjerkén S; Cenci MA; Pomerleau F; Gerhardt GA; Strömberg I
    J Neurochem; 2009 Feb; 108(4):998-1008. PubMed ID: 19196428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel codrugs with GABAergic activity for dopamine delivery in the brain.
    Denora N; Cassano T; Laquintana V; Lopalco A; Trapani A; Cimmino CS; Laconca L; Giuffrida A; Trapani G
    Int J Pharm; 2012 Nov; 437(1-2):221-31. PubMed ID: 22940209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.
    Kabuto H; Yamanushi TT
    Neurochem Res; 2011 Dec; 36(12):2244-9. PubMed ID: 21769642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC.
    Cannazza G; Di Stefano A; Mosciatti B; Braghiroli D; Baraldi M; Pinnen F; Sozio P; Benatti C; Parenti C
    J Pharm Biomed Anal; 2005 Jan; 36(5):1079-84. PubMed ID: 15620535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.
    Glavan G
    Brain Res; 2008 Oct; 1236():216-24. PubMed ID: 18721798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-dopa therapy for Parkinson's disease: past, present, and future.
    Nagatsua T; Sawadab M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S3-8. PubMed ID: 19131039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different levodopa actions on the extracellular dopamine pools in the rat striatum.
    Rodríguez M; Morales I; González-Mora JL; Gómez I; Sabaté M; Dopico JG; Rodríguez-Oroz MC; Obeso JA
    Synapse; 2007 Feb; 61(2):61-71. PubMed ID: 17117421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study.
    D'Aurizio E; Sozio P; Cerasa LS; Vacca M; Brunetti L; Orlando G; Chiavaroli A; Kok RJ; Hennink WE; Di Stefano A
    Mol Pharm; 2011 Dec; 8(6):2408-15. PubMed ID: 22014118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance in oxidant/antioxidant system in different brain regions of rat after the infection of Japanese encephalitis virus.
    Kumar S; Misra UK; Kalita J; Khanna VK; Khan MY
    Neurochem Int; 2009 Dec; 55(7):648-54. PubMed ID: 19549548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selegiline on antioxidant systems in the nigrostriatum in rat.
    Takahata K; Shimazu S; Katsuki H; Yoneda F; Akaike A
    J Neural Transm (Vienna); 2006 Feb; 113(2):151-8. PubMed ID: 15959853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence.
    Carta AR; Frau L; Pontis S; Pinna A; Morelli M
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S165-8. PubMed ID: 18583175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice.
    Azam F; Alkskas IA; Ahmed MA
    Eur J Med Chem; 2009 Oct; 44(10):3889-97. PubMed ID: 19447524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.